Susquehanna International Group, LLP Lantern Pharma Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 07, 2024
BUY
$3.73 - $10.65 $387,920 - $1.11 Million
104,000 New
104,000 $915,000
Q2 2021

Aug 11, 2021
SELL
$12.94 - $19.89 $231,626 - $356,031
-17,900 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$14.34 - $21.92 $256,686 - $392,368
17,900 New
17,900 $325,000

Others Institutions Holding LTRN

# of Institutions
34
Shares Held
1.29M
Call Options Held
39.8K
Put Options Held
6.1K
View Full List

About Lantern Pharma Inc.

LTRN Quotes by TradingView
  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $38.3M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email